Can artificial intelligence function as a partner in scientific discovery, capable of generating novel, testable hypotheses ...

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

The field of oncology continues to confront the formidable challenge of addressing cancer, a leading cause of mortality ...

The healthtech industry is on track to triple from $352 in 2025 to over $1.1T by 2032, driven by critical needs in provider capacity, aging populations, and chronic disease management.

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

The Indian Institute of Technology-Madras announced a breakthrough artificial intelligence framework that can rapidly ...

Researchers at the lab of Nobel laureate David Baker have already developed protein minibinders that perform a similar ...

Researchers at Harvard Medical School developed a tool that uses artificial intelligence to accelerate drug discovery and development. The new technology, called PDGrapher, applies machine learning to ...

Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...

The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive trial designs may ...

Computational drug discovery and design integrates advanced computer‐aided methodologies with chemical and biological insights to accelerate the identification and optimisation of therapeutic agents.